600276.SS
600276.SS
CNE0000014W7
JIANGSU HENGRUI PHARMACEUTICALS
Loading chart...

Company Profile

-

Related stocks

1276.HK
1276.HK • China
HENGRUI PHARMA
48 HKD
40.6B USD 1Y -45.3%
SUNPHARMA.NS
SUNPHARMA.NS • India
SUN PHARMACEUTICAL IND L
1,760 INR
43.63B USD 1Y +7.9%
4502.T
4502.T • Japan
TAKEDA PHARMACEUTICAL CO LTD
5,843 JPY
58.98B USD 1Y +34.8%
688506.SS
688506.SS • China
SICHUAN BIOKIN PHARMACEUTICAL C
229.33 CNY
14.17B USD 1Y -37.4%
TAK
TAK • Japan
Takeda Pharmaceutical Company L
18.73 USD
59.83B USD 1Y +29.4%
000538.SZ
000538.SZ • China
YUNNAN BAIYAO
51.4 CNY
13.72B USD 1Y -10.4%
3692.HK
3692.HK • China
HANSOH PHARMA
31.54 HKD
24.37B USD 1Y -14.8%
002001.SZ
002001.SZ • China
NHU
26.58 CNY
12.22B USD 1Y +6.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country
China
Region
Asia-Pacific
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
33.3% p.a.
Max Drawdown (5Y)
-49.0%
Sharpe Ratio (5Y)
-0.16
Beta Factor
0.04
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (33.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -71.1% in the extended horizon.
ende